相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer
Theodore W. Laetsch et al.
CLINICAL CANCER RESEARCH (2021)
Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer
Derek Wong et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
James P. Solomon et al.
MODERN PATHOLOGY (2020)
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S. Hong et al.
LANCET ONCOLOGY (2020)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors
Anna Forsythe et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Molecular characterization of cancers with NTRK gene fusions
Zoran Gatalica et al.
MODERN PATHOLOGY (2019)
Testing algorithm for identification of patients with TRK fusion cancer
Frederique Penault-Llorca et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy
Susan J. Hsiao et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C. Marchio et al.
ANNALS OF ONCOLOGY (2019)
Identifying patients with NTRK fusion cancer
J. P. Solomon et al.
ANNALS OF ONCOLOGY (2019)
Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study
D. S. Hong et al.
ANNALS OF ONCOLOGY (2019)
TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening
Catherine M. Albert et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy
Alanna J. Church et al.
MODERN PATHOLOGY (2018)
Primary and Metastatic Melanoma With NTRK Fusions
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Theodore W. Laetsch et al.
LANCET ONCOLOGY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib
Victor Wong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib
Victor Wong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement
Dina El Demellawy et al.
PATHOLOGY (2016)
circlize implements and enhances circular visualization in R
Zuguang Gu et al.
BIOINFORMATICS (2014)
Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity
Alena Skalova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
C Tognon et al.
CANCER CELL (2002)
Neurotrophins: Roles in neuronal development and function
EJ Huang et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors
JM Bourgeois et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
分享论文
